Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Statins need no introduction. Although almost unknown 20 years ago, these drugs now are taken by about 1 billion people worldwide. They are popular for good reason: They are easy to take; have minimal side effects; are easy on the wallet; have a measurable biochemical effect; and, importantly, have outstanding clinical benefits for those who take them.
Statins can reduce the risk for cardiovascular (CV) events by 30% or more. They also work across the board—in people with diabetes as well as those without. One question that has remained, however, is whether statin treatment is appropriate in the young diabetes patient or in those at low CV risk.
To address this question, two eminent speakers were invited to debate the issue at the recent annual meeting of the European Association for the Study of Diabetes. The title of the debate was "Statins for All?"[1]
http://www.medscape.com/viewarticle/870803
(free registration)
Statins can reduce the risk for cardiovascular (CV) events by 30% or more. They also work across the board—in people with diabetes as well as those without. One question that has remained, however, is whether statin treatment is appropriate in the young diabetes patient or in those at low CV risk.
To address this question, two eminent speakers were invited to debate the issue at the recent annual meeting of the European Association for the Study of Diabetes. The title of the debate was "Statins for All?"[1]
http://www.medscape.com/viewarticle/870803
(free registration)